ResearcherUniversità Cattolica del Sacro CuoreActive in the last 2 years
Lorenzo Placidi
Matched on ORCID iD 0000-0003-0058-9145; OpenAlex author ID A5019655573. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 25
2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 2 papers
Papers 7
- Evaluating the role of plan complexity metrics in online adaptive radiotherapy for pancreatic cancer patients. Last author DOI 10.1002/mp.70483↗
- Increased cytotoxic effects via combined treatment of magnetic field and radiation therapy in patient-derived organoids of pancreatic ductal adenocarcinoma Co-author DOI 10.21203/rs.3.rs-9009316/v1↗
- Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label… Co-author DOI 10.1016/j.radonc.2023.110064↗
- A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable… Co-author DOI 10.1016/j.ijrobp.2023.05.023↗
- Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Guided Radiotherapy. Co-author DOI 10.3390/diagnostics11010072↗
- On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations. Co-author DOI 10.1016/j.tipsro.2020.06.001↗
- Evaluation of a simplified optimizer for MR-guided adaptive RT in case of pancreatic cancer. Co-author DOI 10.1002/acm2.12697↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Luca Boldrini · 7 shared papers, 2019–2026 · strength 1.10
- Paper Evaluating the role of plan complexity metrics in online adaptive radiotherapy for pancreatic cancer patients. DOI 10.1002/mp.70483↗
- Paper Increased cytotoxic effects via combined treatment of magnetic field and radiation therapy in patient-derived organoids… DOI 10.21203/rs.3.rs-9009316/v1↗
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Michael Frederick Bassetti · 3 shared papers, 2021–2024 · strength 0.38
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Paper Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Gu… DOI 10.3390/diagnostics11010072↗
- Maria Antonietta Gambacorta · 2 shared papers, 2021–2026 · strength 0.34
- Paper Increased cytotoxic effects via combined treatment of magnetic field and radiation therapy in patient-derived organoids… DOI 10.21203/rs.3.rs-9009316/v1↗
- Paper Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Gu… DOI 10.3390/diagnostics11010072↗
- Davide Cusumano · 3 shared papers, 2019–2021 · strength 0.31
- Paper On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations. DOI 10.1016/j.tipsro.2020.06.001↗
- Paper Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Gu… DOI 10.3390/diagnostics11010072↗
- Paper Evaluation of a simplified optimizer for MR-guided adaptive RT in case of pancreatic cancer. DOI 10.1002/acm2.12697↗
- Vincenzo Valentini · 3 shared papers, 2019–2021 · strength 0.31
- Paper On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations. DOI 10.1016/j.tipsro.2020.06.001↗
- Paper Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Gu… DOI 10.3390/diagnostics11010072↗
- Paper Evaluation of a simplified optimizer for MR-guided adaptive RT in case of pancreatic cancer. DOI 10.1002/acm2.12697↗
- Samuele Cavinato · 1 shared paper, 2026 · strength 0.29
- Michael David Chuong · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- John Ng · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Kathryn Elizabeth Mittauer · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Alex T. Price · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Adam Christopher Mueller · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Lorraine Portelance · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Bassem I. Zaki · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Hyun Jee Kim · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Joseph Douglas Mancias · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Lauren E. Henke · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Parag Jitendra Parikh · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Percy P. Lee · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Daniel A. Low · 2 shared papers, 2023–2024 · strength 0.27
- Paper Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancr… DOI 10.1016/j.radonc.2023.110064↗
- Paper A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Rad… DOI 10.1016/j.ijrobp.2023.05.023↗
- Claudio Sette · 1 shared paper, 2026 · strength 0.23
- Giampaolo Tortora · 1 shared paper, 2026 · strength 0.23
- Gian Carlo Mattiucci · 2 shared papers, 2020–2021 · strength 0.23
- Paper On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations. DOI 10.1016/j.tipsro.2020.06.001↗
- Paper Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Gu… DOI 10.3390/diagnostics11010072↗
- Francesco Cellini · 2 shared papers, 2019–2020 · strength 0.20
- Calogero Casà · 1 shared paper, 2021 · strength 0.11
- Marco De Spirito · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.